ʻO Retatrutide (LY3437943)he peptide synthetic hanauna hou i hana ʻia ma ke ʻano heagonist receptor ʻekoluke kuhikuhi nei i nā mea loaʻa GLP-1, GIP, a me glucagon. ʻO kāna hoʻolālā molekala hou e hoʻokaʻawale iā ia mai nā ʻenehana peptide hoʻokahi a me ka pālua-receptor mua, e lilo ia i hoʻokahi o nā hui i aʻo nui ʻia i ka noiʻi metabolic o kēia wā.
Hāʻawi ʻia ma ke ʻano he pauka lyophilized kiʻekiʻe-maʻemaʻe,ʻO Retatrutidehāʻawi i ke kūpaʻa maikaʻi loa no ka lawelawe ʻana i ka hale hana, ka lawe ʻana, a me ka mālama ʻana i ka wā lōʻihi. Hoʻohana pinepine ʻia ia i nā noiʻi ʻepekema e pili ana i ka hōʻailona receptor, ka hoʻoponopono metabolic, ka ʻenekinia peptide, a me ka noiʻi endocrine.
✔ Maʻemaʻe Kiʻekiʻe (≥98% HPLC)
✔ Pauka Lyophilized Keʻokeʻo a Keʻokeʻo ʻOle
✔ Kūlana kūpaʻa maikaʻi loa no nā noi noiʻi
✔ ʻenehana Agonist Receptor Triple
✔ Ka Mana Kūlana Koʻikoʻi a me ke Kūlike o ka Pūʻulu
✔ Kūpono no ka Noiʻi Peptide Kiʻekiʻe
| Mea | Nā kikoʻī |
|---|---|
| Inoa Huahana | ʻO Retatrutide |
| ʻŌlelo like | LY3437943 |
| Formula Molekala | C221H342N46O68* |
| Kaumaha Molekala | Ma kahi o 4731 Da* |
| helehelena | Pauka Lyophilized Keʻokeʻo |
| Maʻemaʻe | ≥98% e HPLC |
| Ka Waihona | -20°C Manaʻo ʻia |
| Ka hiki ke hoʻoheheʻe ʻia | Hoʻoheheʻe ʻia i ka wai |
| Noi | Noiʻi Keʻena Hoʻokolohua Wale Nō |
*Hiki ke ʻokoʻa nā kikoʻī e like me ka hana ʻana a me nā kūlana loiloi.
| Inoa Huahana | Helu CAS |
|---|---|
| AOD-9604 | 221231-10-3 |
| BPC-157 | 137525-51-0 |
| PT-141 / Bremelanotide Acetate | 189691-06-3 |
| CJC-1295 | 863288-34-0 |
| GHK-Cu | 89030-95-5 |
| GHRP-2 | 158861-67-7 |
| Hexarelin | 140703-51-1 |
| IGF-1 LR3 | 946870-92-4 |
| ʻIpamorelin | 170851-70-4 |
| KPV / Alpha MSH (11-13) | 67727-97-3 |
| ʻO L-Arginine | 74-79-3 |
| MOTS-C | 1627580-64-6 |
| ʻOkitokina | 50-56-6 |
| PDA | 106-50-3 |
| ʻO Selank | 129954-34-3 |
| Semax | 80714-61-0 |
| ʻO Sermorelin | 86168-78-7 |
| SS-31 (Lyo) / Elamipretide | 736992-21-5 |
| ʻĀpana TB500 | 476014-70-7 |
| ʻO Tesamorelin | 218949-48-5 |
| ʻO Thymogen / Oglufanide | 38101-59-6 |
| Thymosin Alpha-1 / Thymalfasin | 62304-98-7 |
| ʻO Thymosin Beta-4 | 77591-33-4 |
| TB500 | 885340-08-9 |
| NVG-291 | 2135482-62-7 |
| CB4211 | 2361287-87-0 |
| DSIP | 62568-57-4 |
| ʻEpitalona | 307297-39-8 |
| ʻO Gonadorelin | 33515-09-2 |
| LL-37 | 154947-19-0 |
| Melanotan II | 121062-08-6 |
| MK-0616 | 2249825-14-7 |
| NAD+ | 53-84-9 |
| ʻO Pamorelin | 57773-63-1 |
| PTD-DBM | 1241682-11-0 |
| ʻĀpana 176-191 | 66004-57-7 |
| VIP | 40077-57-4 |
| PE-22-28 | 1136689-11-0 |
Ua hoʻolālā ʻia ʻo Retatrutide e hoʻoulu i ʻekolu mau mea loaʻa hormone metabolic i ka manawa like:
Pili pū me ka hoʻoponopono ʻana i ka makemake, nā ala hoʻokahe ʻōpū, a me nā ʻano hōʻailona e pili ana i ka glucose.
Hoʻokomo ʻia i loko o ke ʻano o ka insulin, ke komo ʻana i nā hana hoʻoponopono metabolic, a me ka ʻike ʻana i nā meaʻai.
Pili i ka hoʻolilo ʻana o ka ikehu, ka metabolism lipid, a me nā ala hoʻololi metabolic.
ʻO ka hoʻoulu ʻia ʻana o kēia mau ʻōnaehana receptor ʻekolu e hoʻolilo iā Retatrutide i mea noiʻi kū hoʻokahi no ka noiʻi ʻana i nā pilina metabolic paʻakikī a me nā pane olaola multi-pathway.
Ua lilo ʻo Retatrutide i kumuhana koʻikoʻi ma kekahi mau wahi o ka noiʻi ʻepekema, e like me:
Ke hoʻomau nei nā mea noiʻi i ka ʻimi ʻana i kāna ʻano kūikawā triple-agonist a me kona mau hopena kūpono no ka hoʻomohala ʻana o ka peptide i ka wā e hiki mai ana.
Pono kēlā me kēia pūʻulu o Retatrutide e hana i nā hoʻāʻo loiloi koʻikoʻi, me:
Hiki ke hāʻawi ʻia kahi Palapala Hōʻoiaʻiʻo (COA) ma ke noi ʻana e hōʻoia i ka maikaʻi o ka huahana a me ka hiki ke hahai ʻia.
No ka mālama ʻana i ke kūpaʻa peptide kūpono:
Ka Mālama ʻana no ka Wā Lōʻihi
Ma hope o ke kūkulu hou ʻana
Kōkua nā kūlana mālama kūpono i ka mālama ʻana i ka pono o ka peptide a me ka hana analytical.
ʻO nā koho hoʻopili i loaʻa e komo pū paha:
Loaʻa nā nui he nui a me nā lawelawe hoʻopili OEM no nā hui noiʻi kūpono.
Hoʻolako wale ʻia ʻo Retatrutide no ka noiʻi hale hana a me nā kumu loiloi wale nō. ʻAʻole ʻae ʻia kēia huahana no ka ʻai kanaka, ka hoʻohana lapaʻau, ka hoʻohana therapeutic, a i ʻole nā kaʻina hana diagnostic. Na nā mea noiʻi ke kuleana no ka hōʻoia ʻana i ka mālama ʻana i nā lula āpau a me nā alakaʻi o ka ʻoihana.